1. Röder, Annika, Hüsken, Saskia, Hutter, Michael C, Wiek, Constanze, Girhard, Marco. 2023. Spotlight on CYP4B1. In International journal of molecular sciences, 24, . doi:10.3390/ijms24032038. https://pubmed.ncbi.nlm.nih.gov/36768362/
2. Lim, Sym, Alshagga, M, Ong, C E, Chieng, J Y, Pan, Y. 2020. Cytochrome P450 4B1 (CYP4B1) as a target in cancer treatment. In Human & experimental toxicology, 39, 785-796. doi:10.1177/0960327120905959. https://pubmed.ncbi.nlm.nih.gov/32054340/
3. Yu, Shuyong, Chen, Zhuang, Cheng, Jiajia, Zhong, Ping, Song, Jian. 2022. Case-control study on CYP4B1 gene polymorphism and susceptibility to gastric cancer in the chinese Han population. In BMC medical genomics, 15, 223. doi:10.1186/s12920-022-01367-w. https://pubmed.ncbi.nlm.nih.gov/36307788/
4. Yang, Ling, Yu, Xueyuan, Liu, Meng, Cao, Yang. 2023. A comprehensive analysis of biomarkers associated with synovitis and chondrocyte apoptosis in osteoarthritis. In Frontiers in immunology, 14, 1149686. doi:10.3389/fimmu.2023.1149686. https://pubmed.ncbi.nlm.nih.gov/37545537/
5. Hiratsuka, Masahiro, Nozawa, Hisayoshi, Konno, Yumiko, Konno, Shoetsu, Mizugaki, Michinao. . Human CYP4B1 gene in the japanese population analyzed by denaturing HPLC. In Drug metabolism and pharmacokinetics, 19, 114-9. doi:. https://pubmed.ncbi.nlm.nih.gov/15499177/
6. Liu, Xiaoling, Jia, Yichen, Shi, Changyuan, Wei, Anjie, Wang, Dan. 2021. CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma. In PloS one, 16, e0247020. doi:10.1371/journal.pone.0247020. https://pubmed.ncbi.nlm.nih.gov/33592039/